Book contents
- Core Topics in Anaesthesia and Peri-operative Care of the Morbidly Obese Surgical Patient
- Core Topics in Anaesthesia and Peri-operative Care of the Morbidly Obese Surgical Patient
- Copyright page
- Contents
- Contributors
- Preface
- Abbreviations
- Section 1 Background to Obesity, Epidemiology and Anthropology
- Section 2 Pathophysiology of Obesity
- Chapter 6 Cardiovascular System Pathophysiology in Obesity
- Chapter 7 The Respiratory System and Airway Pathophysiology in Obesity
- Chapter 8 The Pathophysiology of Sleep Disordered Breathing in the Morbidly Obese
- Chapter 9 Drug Compartments and Body Systems
- Chapter 10 Diabetes Mellitus and the Metabolic Syndrome
- Section 3 Pre-operative Assessment and Preparation
- Section 4 Intra-operative Management
- Section 5 Post-operative Care
- Section 6 Bariatric Surgery
- Index
- References
Chapter 9 - Drug Compartments and Body Systems
from Section 2 - Pathophysiology of Obesity
Published online by Cambridge University Press: 24 September 2018
Book contents
- Core Topics in Anaesthesia and Peri-operative Care of the Morbidly Obese Surgical Patient
- Core Topics in Anaesthesia and Peri-operative Care of the Morbidly Obese Surgical Patient
- Copyright page
- Contents
- Contributors
- Preface
- Abbreviations
- Section 1 Background to Obesity, Epidemiology and Anthropology
- Section 2 Pathophysiology of Obesity
- Chapter 6 Cardiovascular System Pathophysiology in Obesity
- Chapter 7 The Respiratory System and Airway Pathophysiology in Obesity
- Chapter 8 The Pathophysiology of Sleep Disordered Breathing in the Morbidly Obese
- Chapter 9 Drug Compartments and Body Systems
- Chapter 10 Diabetes Mellitus and the Metabolic Syndrome
- Section 3 Pre-operative Assessment and Preparation
- Section 4 Intra-operative Management
- Section 5 Post-operative Care
- Section 6 Bariatric Surgery
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Core Topics in Anaesthesia and Peri-operative Care of the Morbidly Obese Surgical Patient , pp. 45 - 52Publisher: Cambridge University PressPrint publication year: 2018
References
Further Reading
Andreasen, PB, Dano, P, Kirk, H, Greisen, G Drug absorption and hepatic drug metabolism in patients with different types of intestinal shunt operation for obesity: a study with phenazone Scand J Gastroenterol. 1977;5:531–5.Google Scholar
Benedek, IH, Blouin, RA, McNamara, PJ Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects. Br J Clin Pharmacol. 1984;6:941–6.Google Scholar
Benedek, IH, Fiske, WD 3rd, Griffen, WO, et al. Serum alpha 1-acid glycoprotein and the binding of drugs in obesity. Br J Clin Pharmacol. 1983;6:751–4.Google Scholar
Blouin, RA, Warren, GW Pharmacokinetic considerations in obesity. J Pharm Sci. 1999;1:1–7.Google Scholar
Bowman, SL, Hudson, SA, Simpson, G, Munro, JF, Clements, JA A comparison of the pharmacokinetics of propranolol in obese and normal volunteers Br J Clin Pharmacol. 1986;5:529–32.Google Scholar
Brill, MJ, Diepstraten, J, van Rongen, A, et al. Impact of obesity on drug metabolism and elimination in adults and children Clin Pharmacokinet. 2012;5:277–304.Google Scholar
Brodsky, JB, Lemmens, HJ Anesthetic Management of the Obese Surgical Patient. Cambridge: Cambridge University Press; 2011.CrossRefGoogle Scholar
Carron, M, Freo, U, Parotto, E, Ori, C The correct dosing regimen for sugammadex in morbidly obese patients. Anaesthesia. 2012;3:298–9.Google Scholar
Cortinez, LI, Anderson, BJ, Penna, A, et al. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anaesth. 2010;4:448–56.Google Scholar
Cortinez, LI, De la Fuente, N, Eleveld, DJ, et al. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis. Anesth Analg. 2014;2:302–10.Google Scholar
Das, SK, Roberts, SB, McCrory, MA, et al. Long-term changes in energy expenditure and body composition after massive weight loss induced by gastric bypass surgery. Am J Clin Nutr. 2003;1:22–30.CrossRefGoogle Scholar
Ducharme, MP, Slaughter, RL, Edwards, DJ Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit. 1994;5: 513–18.Google Scholar
DuBois, D, DuBois, EF A formula to estimate the approximate surface area if height and weight be known. Arch Int Med. 1916;17:863–71.Google Scholar
Egan, TD, Huizinga, B, Gupta, SK, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology. 1998;3:562–73.Google Scholar
Erstad, BL, Patanwala, AE Ketamine for analgosedation in critically ill patients. J Crit Care. 2016:145–149.CrossRefGoogle Scholar
Graves, DA, Batenhorst, RL, Bennett, RL, et al. Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity. Clin Pharm. 1983;1:49–53.Google Scholar
Green, B, Duffull, SB What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 2004;2:119–33.Google Scholar
Greenblatt, DJ, Abernethy, DR, Locniskar, A, et al. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology. 1984;1:27–35.CrossRefGoogle Scholar
Gurney, H Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative. J Clin Oncol. 1996;9:2590–611.Google Scholar
Han, PY, Duffull, SB, Kirkpatrick, CM, Green, B Dosing in obesity: a simple solution to a big problem. Clin Pharmacol Ther. 2007;5:505–8.Google Scholar
Ingrande, J, Brodsky, JB, Lemmens, HJ Lean body weight scalar for the anesthetic induction dose of propofol in morbidly obese subjects. Anesth Analg. 2011;1:57–62.Google Scholar
Ingrande, J, Lemmens, HJ Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. 2010:i16–23.Google Scholar
Janmahasatian, S, Duffull, SB, Ash, S et al. Quantification of lean bodyweight. Clin Pharmacokinet. 2005;44:1051–65Google Scholar
Juvin, P, Vadam, C, Malek, L, et al. Postoperative recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients: a prospective, randomized study. Anesth Analg. 2000;3:714–19.Google Scholar
Keys, A, Fidanza, F, Karvonen, MJ, Kimura, N, Taylor, HL Indices of relative weight and obesity. J Chronic Dis. 1972;25(6–7):329–43.CrossRefGoogle ScholarPubMed
Kirkegaard-Nielsen, H, Helbo-Hansen, HS, Lindholm, P, Severinsen, IK, Pedersen, HS Anthropometric variables as predictors for duration of action of atracurium-induced neuromuscular block. Anesth Analg. 1996;5:1076–80.Google Scholar
Kyle, UG, Piccoli, A, Pichard, C Body composition measurements: interpretation finally made easy for clinical use. Curr Opin Clin Nutr Metab Care. 2003;4:387–93.Google Scholar
La Colla, L, Albertin, A, La Colla, G, et al. Predictive performance of the ‘Minto’ remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass. Clin Pharmacokinet. 2010;2:131–9.Google Scholar
Lemmens, HJ, Brodsky, JB The dose of succinylcholine in morbid obesity. Anesth Analg. 2006;2:438–42.Google Scholar
Lemmens, HJ, Brodsky, JB, Bernstein, DP Estimating ideal body weight–a new formula. Obes Surg. 2005;5(7):1082–3.Google Scholar
Lemmens, HJ, Saidman, LJ, Eger, EI, 2nd, Laster, MJ Obesity modestly affects inhaled anesthetic kinetics in humans. Anesth Analg.2008;6:1864–70.Google Scholar
Leykin, Y, Pellis, T, Lucca, M, et al. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg. 2004;4:1086–9.Google Scholar
Linares, CL, Decleves, X, Oppert, JM, et al. Pharmacology of morphine in obese patients. Clin Pharmacokinet. 2009;10:635–51.Google Scholar
Martinoli, R, Mohamed, EI, Maiolo, C, et al. Total body water estimation using bioelectrical impedance: a meta-analysis of the data available in the literature. Acta Diabetol. 2003:S203–6.CrossRefGoogle Scholar
McCarron, MM, Devine, BJ Clinical pharmacy: case studies case number 25 gentamicin therapy. Ann Pharmacother. 1974;11:650–5.Google Scholar
McLeay, SC, Morrish, GA, Kirkpatrick, CM, Green, B The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007. Clin Pharmacokinet. 2012;5:319–30.Google Scholar
Miller, D, Carlson, J, Loyd, B, Day, B Determining ideal body weight (letter). Am J Hosp Pharm. 1983:1622.Google Scholar
Monk, TG, Rietbergen, H, Woo, T, Fennema, H Use of sugammadex in patients with obesity: a pooled analysis. Am J Thera. 2015;24(5):e507–16.Google Scholar
Moore, FD Energy and the maintenance of the body cell mass. J Parent Ent Nutr. 1980;3:228–60.Google Scholar
Moretto, M, Kupski, C, Mottin, CC, et al. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Obes Surg. 2003;4:622–4.Google Scholar
Mosteller, RD Simplified calculation of body-surface area. N Engl J Med. 1987;17:1098.Google Scholar
Nightingale, CE, Margarson, MP, Shearer, E, et al. Peri-operative management of the obese surgical patient 2015. Anaesthesia. 2015;7:859–76.Google Scholar
Pai, MP, Paloucek, FP The origin of the ‘ideal’ body weight equations. Ann Pharmacother. 2000:1066–9.Google Scholar
Reiss, RA, Haas, CE, Karki, SD, et al. Lithium pharmacokinetics in the obese. Clin Pharmacol Ther. 1994;4:392–8.Google Scholar
Robinson, JD, Lupkiewicz, SM, Palenik, L, Lopez, LM, Ariet, M. Determination of ideal body weight for drug dosage calculations. Am J Hosp Pharm. 1983;6:1016–19.Google Scholar
Rose, DK, Cohen, MM, Wigglesworth, DF, DeBoer, DP Critical respiratory events in the postanesthesia care unit: patient, surgical, and anesthetic factors. Anesthesiology. 1994;2:410–18.Google Scholar
Sakizci-Uyar, B, Celik, S, Postaci, A, et al. Comparison of the effect of rocuronium dosing based on corrected or lean body weight on rapid sequence induction and neuromuscular blockade duration in obese female patients Saudi Med J. 2016;1:60–5.Google Scholar
Schwartz, AE, Matteo, RS, Ornstein, E, Halevy, JD, Diaz, J Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient. Anesth Analg. 1992;4:515–18.Google Scholar
Servin, F, Farinotti, R, Haberer, JP, Desmonts, JM Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide: a clinical and pharmacokinetic study. Anesthesiology. 1993;4:657–65.Google Scholar
Sharma, V, McNeill, JH To scale or not to scale: the principles of dose extrapolation Br J Pharmacol. 2009;6:907–21.Google Scholar
Shibutani, K, Inchiosa, MA, Jr, Sawada, K, Bairamian, M Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth. 2005;3:377–83.Google Scholar
Stokholm, KH, Brochner-Mortensen, J, Hoilund-Carlsen, PFIncreased glomerular filtration rate and adrenocortical function in obese women. Int J Obes. 1980;1:57–63.Google Scholar
Strum, EM, Szenohradszki, J, Kaufman, WA, et al. Emergence and recovery characteristics of desflurane versus sevoflurane in morbidly obese adult surgical patients: a prospective, randomized study. Anesth Analg. 2004;6:1848–53.Google Scholar
Van Lancker, P, Dillemans, B, Bogaert, T, et al. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients. Anaesthesia. 2011;8:721–5.Google Scholar
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;9403:157–63.Google Scholar